Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas-Reference-Cited by-同舟云学术

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

Published:2012-02-23 Issue:4 Volume:123 Page:473-484
ISSN:0001-6322
Container-title:Acta Neuropathologica
language:en
Short-container-title:Acta Neuropathol

Author:

Kool Marcel,Korshunov Andrey,Remke Marc,Jones David T. W.,Schlanstein Maria,Northcott Paul A.,Cho Yoon-Jae,Koster Jan,Schouten-van Meeteren Antoinette,van Vuurden Dannis,Clifford Steven C.,Pietsch Torsten,von Bueren Andre O.,Rutkowski Stefan,McCabe Martin,Collins V. Peter,Bäcklund Magnus L.,Haberler Christine,Bourdeaut Franck,Delattre Olivier,Doz Francois,Ellison David W.,Gilbertson Richard J.,Pomeroy Scott L.,Taylor Michael D.,Lichter Peter,Pfister Stefan M.

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Pathology and Forensic Medicine

Link

http://www.springerlink.com/index/pdf/10.1007/s00401-012-0958-8

Reference26 articles.

1. Cho YJ, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, Berhoukim R, Amani V, Goumnerova L, Eberhart CG, Lau CC, Olson JM, Gilbertson RJ, Gajjar A, Delattre O, Kool M, Ligon K, Meyerson M, Mesirov JP, Pomeroy SL (2011) Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol 29(11):1424–1430

2. Clifford SC, Lusher ME, Lindsey JC, Langdon JA, Gilbertson RJ, Straughton D, Ellison DW (2006) Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. Cell Cycle 5(22):2666–2670

3. Ellison DW, Dalton J, Kocak M, Nicholson SL, Fraga C, Neale G, Kenney AM, Brat DJ, Perry A, Yong WH, Taylor RE, Bailey S, Clifford SC, Gilbertson RJ (2011) Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol 121(3):381–396

4. Ellison DW, Onilude OE, Lindsey JC, Lusher ME, Weston CL, Taylor RE, Pearson AD, Clifford SC (2005) Beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children’s Cancer Study Group Brain Tumour Committee. J Clin Oncol 23(31):7951–7957

5. Fattet S, Haberler C, Legoix P, Varlet P, Lellouch-Tubiana A, Lair S, Manie E, Raquin MA, Bours D, Carpentier S, Barillot E, Grill J, Doz F, Puget S, Janoueix-Lerosey I, Delattre O (2009) Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics. J Pathol 218(1):86–94

Cited by 840 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aberrant FGF signaling promotes granule neuron precursor expansion in SHH subgroup infantile medulloblastoma;2024-09-12

2. Aberrant FGF signaling promotes granule neuron precursor expansion in SHH subgroup infantile medulloblastoma;2024-09-12

3. Predicting response to chemotherapy in brain tumor patients based on MRI features;Clinical Neurology and Neurosurgery;2024-09

4. Immunoexpression of Survivin and P53 in the Histological Subtypes of Medulloblastoma: A Cross-Sectional Observational Study;Cureus;2024-07-29

5. Radiomics and artificial intelligence applications in pediatric brain tumors;World Journal of Pediatrics;2024-06-27